RICTOR and pancreatic neoplasm: Indeed, we and others have shown that treatment of pancreatic cancer cells with the mTORC1 inhibitor rapamycin induces AKTSer473 phosphorylation which can be abrogated by simultaneous RICTOR inhibition [24].